Membrane cholesterol as regulator of human rhomboid protease RHBDL4

The Journal of Biological Chemistry
Sandra PaschkowskyLisa Marie Munter

Abstract

In the last decade, intramembrane proteases have gained increasing attention because of their many links to various diseases. Nevertheless, our understanding as to how they function or how they are regulated is still limited, especially when it comes to human homologues. In this regard, here we sought to unravel mechanisms of regulation of the protease rhomboid-like protein-4 (RHBDL4), one of five active human serine intramembrane proteases. In view of our recent finding that human RHBDL4 efficiently cleaves the amyloid precursor protein (APP), a key protein in the pathology of Alzheimer's disease, we used established reagents to modulate the cellular cholesterol content and analyzed the effects of this modulation on RHBDL4-mediated processing of endogenous APP. We discovered that lowering membrane cholesterol levels increased the levels of RHBDL4-specific endogenous APP fragments, whereas high cholesterol levels had the opposite effect. Direct binding of cholesterol to APP did not mediate these modulating effects of cholesterol. Instead, using homology modeling, we identified two potential cholesterol-binding motifs in the transmembrane helices 3 and 6 of RHBDL4. Substitution of the essential tyrosine residues of the potential...Continue Reading

References

Feb 1, 1990·Nature·J L Goldstein, M S Brown
Jan 1, 1983·Methods in Enzymology·J L GoldsteinM S Brown
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Sep 29, 1999·Neuroreport·E R FrearsB M Austen
Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·K FassbenderT Hartmann
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·E KojroF Fahrenholz
May 10, 2001·Proceedings of the National Academy of Sciences of the United States of America·B Wolozin
Sep 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bethany A Janowski
Mar 27, 2003·Nature Neuroscience·Luigi PuglielliDora M Kovacs
Jan 27, 2004·The Annals of Pharmacotherapy·Lisa J Miller, Reni Chacko
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sinisa Urban, Michael S Wolfe
Mar 12, 2005·Journal of the Neurological Sciences·Christina SideraBrian Austen
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·M Joanne LemieuxMichael N G James
Nov 3, 2007·Journal of Molecular Biology·Yongcheng WangYa Ha
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Gerrit van MeerGerald W Feigenson
Feb 28, 2009·Nature Protocols·Lawrence A Kelley, Michael J E Sternberg
Mar 13, 2009·Structure·Ana-Nicoleta BondarStephen H White
Apr 2, 2011·The Journal of Biological Chemistry·Massoud MotamedMichael S Brown
Apr 5, 2013·EMBO Molecular Medicine·Nathalie PierrotJean-Noël Octave
Mar 31, 2015·Cell·Joseph L Goldstein, Michael S Brown
Apr 25, 2015·Biochemistry·Haizhi WangAleister Saunders
May 8, 2015·Nature Protocols·Lawrence A KelleyMichael J E Sternberg
Nov 8, 2015·Biochemical and Biophysical Research Communications·Jinsil KimDong-Uk Kim
Feb 27, 2016·Scientific Reports·Jacques FantiniFrancisco J Barrantes
Jul 6, 2016·Seminars in Cell & Developmental Biology·Marius K Lemberg, Colin Adrain

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.